|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.74 USD | -1.70% |
|
-11.38% | +1.24% |
| 08-04 | Indivior Pharmaceuticals, Inc. Enters into Senior Secured Term Loan Facility | CI |
| 08-04 | Indivior Pharmaceuticals, Inc. Proposes Special Cash Dividend | CI |
| Market Cap | 4.56B 3.96B 3.69B 3.39B 6.41B 433B 6.48B 43.49B 17B 217B 17.11B 16.74B 718B | P/E 2026 * |
9.89x | P/E 2027 * | 9.68x |
|---|---|---|---|---|---|
| Enterprise Value | 4.61B 4B 3.73B 3.43B 6.49B 439B 6.56B 44.01B 17.2B 219B 17.31B 16.94B 726B | EV / Sales 2026 * |
3.52x | EV / Sales 2027 * | 3.13x |
| Free-Float |
97.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Indivior Pharmaceuticals, Inc.
| 1 day | -1.74% | ||
| 1 week | -11.38% | ||
| Current month | -9.21% | ||
| 1 month | -9.16% | ||
| 3 months | -6.81% | ||
| 6 months | +5.78% | ||
| Current year | +1.24% |
| 1 week | 35.76 |  | 41.65 |
| 1 month | 35.76 | | 41.84 |
| Current year | 27.68 | | 42.81 |
| 1 year | 21.16 | | 42.81 |
| 3 years | 7.33 | | 42.81 |
| 5 years | 7.33 | | 42.81 |
| 10 years | 1.75 | | 42.81 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/07/26 | Sell | Chief Scientific Officer | -18,586 | 0.0152% | ||
| 13/05/26 | Free | Director | 6,518 | 0.0053% | ||
| 10/02/26 | Free | Executive/Senior Manager | 31,380 | 0.0251% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.70% | -11.38% | +71.18% | +63.26% | 4.56B | |
| -0.56% | -7.94% | +46.13% | +150.01% | 1T | |
| -0.12% | -4.95% | +48.23% | +49.99% | 613B | |
| -0.47% | -7.39% | +23.61% | +65.00% | 433B | |
| +0.48% | -2.77% | +40.27% | +34.96% | 350B | |
| +0.08% | -4.45% | +31.74% | +39.89% | 292B | |
| +2.09% | -9.27% | +5.42% | +7.61% | 239B | |
| +1.75% | -8.29% | -1.73% | -42.05% | 206B | |
| +2.17% | -1.63% | +28.07% | +58.95% | 204B | |
| +0.10% | -2.32% | +14.58% | +66.75% | 163B | |
| Average | +0.44% | -4.16% | +30.75% | +49.44% | 350.5B | |
| Weighted average by Cap. | +0.25% | -4.34% | +33.86% | +71.06% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.31B 1.14B 1.06B 975M 1.84B 125B 1.86B 12.51B 4.89B 62.35B 4.92B 4.82B 207B | 1.33B 1.15B 1.07B 987M 1.87B 126B 1.89B 12.67B 4.95B 63.12B 4.99B 4.88B 209B |
| Net income | 474M 411M 383M 352M 666M 45.06B 674M 4.52B 1.77B 22.52B 1.78B 1.74B 74.63B | 487M 423M 394M 362M 685M 46.33B 693M 4.65B 1.82B 23.16B 1.83B 1.79B 76.74B |
| Net Debt | 54.5M 47.32M 44.12M 40.53M 76.66M 5.18B 77.5M 520M 203M 2.59B 205M 200M 8.59B | -403M -350M -327M -300M -567M -38.37B -574M -3.85B -1.51B -19.18B -1.51B -1.48B -63.56B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/08/26 | $36.32 | -2.82% | 3,314,878 |
| 03/08/26 | $37.37 | -6.60% | 6,683,681 |
| 31/07/26 | $40.01 | -0.52% | 1,351,833 |
| 30/07/26 | $40.22 | +0.30% | 1,580,952 |
| 29/07/26 | $40.10 | -2.17% | 1,496,235 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INDV Stock
Select your edition
All financial news and data tailored to specific country editions
